Clinical Trial Update: A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the COACH program for management of dyslipidemia; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Dyslipidemia | Phase 4 | Status: COMPLETED